Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - TripCo Outstanding Awards (Details)

v3.19.1
Stock-Based Compensation - TripCo Outstanding Awards (Details) - 2014 Plan
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2019
USD ($)
$ / shares
shares
Stock-Based Compensation  
Dividend rate 0.00%
Additional disclosures  
Unvested value not yet recognized | $ $ 4
Weighted average period the unrecognized compensation cost will be recognized 1 year
Common Stock, Capital Shares Reserved for Future Issuance 2,400,000
Series A | Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding beginning balance 570,000
Granted 0
Outstanding ending balance 570,000
Options exercisable 509,000
WAEP  
Weighted average exercise price, options outstanding (in dollars per share) | $ / shares $ 15.40
Weighted average exercise price, options outstanding (in dollars per share) | $ / shares 15.40
Weighted average exercise price, options exercisable (in dollars per share) | $ / shares $ 14.87
Weighted average remaining contractual term outstanding 3 years
Weighted average remaining contractual term exercisable 2 years 6 months
Outstanding, aggregate intrinsic value | $ $ 1
Exercisable, aggregate intrinsic value | $ $ 1
Series B | Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding beginning balance 1,797,000
Granted 27,000
Outstanding ending balance 1,824,000
Options exercisable 899,000
WAEP  
Weighted average exercise price, options outstanding (in dollars per share) | $ / shares $ 27.83
Weighted average exercise price, options granted (in dollars per share) | $ / shares 14.28
Weighted average exercise price, options outstanding (in dollars per share) | $ / shares 27.63
Weighted average exercise price, options exercisable (in dollars per share) | $ / shares $ 27.83
Weighted average remaining contractual term outstanding 5 years 9 months 18 days
Weighted average remaining contractual term exercisable 5 years 8 months 12 days
Series B | Stock Options | CEO  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Granted 27,000
Additional disclosures  
Weighted average grant date fair value, options (in dollars per share) | $ / shares $ 6.41
Series B | Restricted Stock Units (RSUs) | CEO  
Additional disclosures  
RSUs granted 35,000
Weighted average grant date fair value, granted during period RSUs (in dollars per share) | $ / shares $ 14.17
Vesting period 1 year